DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System

Information source: Tianjin Medical University General Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: The Intraoperative Effect of Dexmedetomidine on Cisatracurium Infusion Consumption and Its Recovery Index.; Effect of Dexmedetomidine on Sufentanil Consumption.; Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age Groups.

Intervention: Effect of dexmedetomidine on cisatracurium and sufentanil consumption (Drug); Consumption of cisatracurium and sufentanil in different age groups. (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Tianjin Medical University General Hospital

Official(s) and/or principal investigator(s):
Guolin Wang, MD, PhD, Professor, Principal Investigator, Affiliation: Tianjin Medical University General Hospital

Overall contact:
Shehzaad Joomye, M.D., Phone: 8613072283346, Email: s_joomye@hotmail.com

Summary

The purpose of this study is to:

- determine the effect of dexmedetomidine on cisatracurium infusion requirements and

sufentanil consumption.

- analyze the cisatracurium infusion requirements and sufentanil consumption in different

age groups.

Clinical Details

Official title: Effect of Dexmedetomidine on Cisatracurium Infusion and Sufentanil Consumption and Its Variations in Different Age Groups, Using a Closed Loop Computer Controlled System.

Study design: Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Primary outcome: Cisatracurium infusion consumption.

Secondary outcome: Sufentanil consumption.

Eligibility

Minimum age: 18 Years. Maximum age: 85 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- ASA status 1 and 2.

- Consent approval written and oral.

- Patients scheduled for elective abdominal surgery under general anesthesia.

Exclusion Criteria:

- Patients with neuromuscular disorders.

- Patients with history of stroke, flaccid paralysis or other neurological disorders.

- Significant renal, hepatic or cardiac dysfunction.

- Consent refusal.

Locations and Contacts

Shehzaad Joomye, M.D., Phone: 8613072283346, Email: s_joomye@hotmail.com

Tianjin Medical University General Hospital, Tianjin, Tianjin 300052, China; Recruiting
Guolin Wang, MD, PhD, Professor, Principal Investigator
Shehzaad Joomye, MD, Principal Investigator
Haiyun Wang, MD, PhD, Sub-Investigator
Donglai Yan, MD, Sub-Investigator
Additional Information

Starting date: November 2012
Last updated: February 6, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017